Supernus Pharmaceuticals (SUPN) PT Lowered to $37 at Piper Sandler

November 4, 2021 9:39 AM EDT Send to a Friend

Piper Sandler analyst David Amsellem ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Supernus Pharmaceuticals (SUPN) PT Lowered to $37 at Piper Sandler

Member Login

Free News Feed